Results 1 to 10 of about 76,423 (194)

Immune compromise in HIV-1/HTLV-1 coinfection with paradoxical resolution of CD4 lymphocytosis during antiretroviral therapy: a case report [PDF]

open access: yes, 2015
Human immunodeficiency virus type-1 (HIV-1) and human T lymphotropic virus type-1 (HTLV-1) infections have complex effects on adaptive immunity, with specific tropism for, but contrasting effects on, CD4 T lymphocytes: depletion with HIV-1, proliferation
Bangham, C   +6 more
core   +2 more sources

Opportunistic illnesses in Brazilian children with AIDS: results from two national cohort studies, 1983-2007

open access: yesAIDS Research and Therapy, 2011
Background HAART has significantly reduced AIDS-related morbidity in children. However, limited evidence is available from developing countries regarding patterns of opportunistic illnesses.
Heukelbach Jorg   +3 more
doaj   +1 more source

Pricing of drugs and donations: options for sustainable equity pricing. [PDF]

open access: yes, 2001
Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines.
Ford, N, Herranz, E, Pérez-Casas, C
core   +2 more sources

Involvement of People Living with HIV/AIDS in Treatment Preparedness in Thailand [PDF]

open access: yes, 2004
Perspective and Practice in Antiretroviral Treatment: Case ...
Kumphitak, A   +4 more
core   +1 more source

EPIDEMIOLOGICAL ASPECTS OF HIV-TB CO-INFECTION IN PEOPLE WITH HIV/AIDS (PLWHA): A HOSPITAL-BASED STUDY

open access: yesThe Indonesian Journal of Public Health
Introduction : Tuberculosis (TB) is one of the co-infections with high morbidity and mortality in patients with HIV/AIDS (PLWHA). The prevalence of Tuberculosis in HIV patients in Indonesia ranges from 19.7% to 61.5%.
Rico januar Sitorus   +4 more
doaj   +1 more source

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières [PDF]

open access: yes, 2008
OBJECTIVES: To describe the use of second-line protease-inhibitor regimens in Médecins Sans Frontières HIV programmes, and determine switch rates, clinical outcomes, and factors associated with survival.
Alexandra Calmy   +24 more
core   +2 more sources

Chinese guidelines for the diagnosis and treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (2024 edition)

open access: yesInfectious Diseases & Immunity
. The Acquired Immunodeficiency Syndrome Professional Group of the Society of Infectious Diseases of the Chinese Medical Association formulated the first edition of the Chinese Guidelines for the Diagnosis and Treatment of human immunodeficiency virus ...
Acquired Immunodeficiency Syndrome Professional Group, Society of Infectious Diseases, Chinese Medical Association; Chinese Center for Disease Control and Prevention   +1 more
doaj   +3 more sources

HIV- Positive Person - Marriage, Pregnancy and Perinatal/ Vertical/ Mother to Child Transmission: Awareness, Prevention and Recommendations

open access: yesJLUMHS
Human Immunodeficiency Virus (HIV) / Acquired Immunodeficiency Syndrome (AIDS) is a major global public health problem. At present, more than 40 million persons are living with HIV, and 42 million persons have died from AIDS-related opportunistic ...
Nasreen Inayat Bughio
doaj   +1 more source

Chinese Guideline for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome (2024 Edition)

open access: yesXiehe Yixue Zazhi
In 2005, the Acquired Immunodeficiency Syndrome Professional Group of Society of Infectious Diseases, Chinese Medical Association formulated the "Guideline for Diagnosis and Treatment of AIDS" in China (hereinafter referred to as the "Guideline").
Acquired Immunodeficiency Syndrome Professional Group of Society of Infectious Diseases, Chinese Medical Association   +1 more
doaj   +1 more source

Access to HIV Prevention: Closing the Gap [PDF]

open access: yes, 2003
Provides a region-by-region analysis of intervention gaps, examines current spending levels versus projected need, and recommends funding and programmatic activities to avert 29 million of the 45 million new HIV infections projected between 2002 and ...

core  

Home - About - Disclaimer - Privacy